Eloxx Pharmaceuticals, Inc. (ELOX) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Eloxx Pharmaceuticals, Inc. (ELOX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $95.3M, listed on NASDAQ, employing roughly 10 people, carrying a beta of -24.60 to the broader market. Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical firm that specializes in developing therapeutic solutions through ribosome modulation. Led by Sumit Aggarwal, public since 2026-06-09.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for ELOX as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →